X
Get new exclusive access to healthcare business reports & breaking news
Pharma
Pharmaceutical companies and pharmacy benefit managers testified in front of the U.S. Senators May 10th, during a hearing ...
Biopharma contract manufacturers (CDMOs) are racing to ramp up their capabilities in response to a glaring shortage of ...
Another patent contest is brewing between Big Pharma giants Amgen and Johnson & Johnson (J&J). Amgen has set ...
With exciting prospects ahead, Biogen Inc. has appointed Adam Keeney as head of corporate development to help expand ...
Pfizer has announced its intention to purchase Seagen for a whopping $43 billion in order to further its ...
Sanofi SA, the renowned French drugmaker, has announced its plans to shell out a staggering $2.9 billion to ...
Merck & Co. Inc.’s experimental TIGIT drug, vibostolimab, failed to meet its primary endpoint in a Phase 2 ...
Although Ipsen’s Palovarotene was rejected by the FDA just three months ago, the rare disease candidate’s story is ...
Last week proved to be a challenging one for Sangamo Therapeutics. The gene-based therapy biotech company recently announced ...
